首页 > 最新文献

Journal of Clinical Laboratory Analysis最新文献

英文 中文
Novel Germline KIT Variants in Families With Severe Piebaldism: Case Series and Literature Review 重度胼胝体畸形家族中的新型基因 KIT 变异:病例系列和文献综述
IF 2.6 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-17 DOI: 10.1002/jcla.25073
Yuanyuan Zhang, Haiming Gao, Lu Zhang, Yunjing Zhao, Chuang Qiu, Xiaoliang Liu

Introduction

Piebaldism is a rare autosomal dominant disorder characterized by congenital white forelock and depigmented patches, which is most commonly caused by deleterious variants in the KIT gene.

Methods

Four KIT variants were identified in a piebaldism case series by whole-exome sequencing. Functional experiments, including in vitro minigene reporter assay and enzyme-linked immunosorbent assay, were carried out to elucidate the pathogenicity of the variants. The genotype–phenotype correlation was summarized through extensive literature reviewing.

Results

All the four cases had severe piebaldism presented with typical white forelock and diffuse depigmentation on the ventral trunk and limbs. Four germline variants at the tyrosine kinase (TK) domains of the KIT gene were identified: two novel variants c.1990+1G>A (p.Pro627_Gly664delinsArg) and c.2716T>C (p.Cys906Arg), and two known variants c.1879+1G>A (p.Gly592_Pro627delinsAla) and c.1747G>A (p.Glu583Lys). Both splicing variants caused exon skipping and inframe deletions in the TK1 domain. The missense variants resided at the TK1 and TK2 domains respectively impairing PI3K/AKT and MAPK/ERK signaling pathways, the downstream of KIT. All severe cases were associated with variants in the TK domains, eliciting a major dominant-negative mechanism of the disease.

Conclusion

Our data expand the mutation spectrum of KIT, emphasized by a dominant-negative effect of variants in the critical TK domains in severe cases. We also share the experience of prenatal diagnosis and informed reproductive choices for the affected families.

简介骓斑症是一种罕见的常染色体显性遗传疾病,以先天性白前额和色素脱失斑为特征,最常见的病因是 KIT 基因中的有害变体:方法:通过全外显子组测序,在派秃症病例系列中发现了四个 KIT 变异基因。方法:通过全外显子组测序在一个胼胝体畸形病例系列中发现了四个 KIT 变异基因,并进行了功能实验,包括体外微型基因报告实验和酶联免疫吸附实验,以阐明这些变异基因的致病性。通过查阅大量文献,总结了基因型与表型的相关性:结果:四例病例均患有严重的骓症,表现为典型的白色前锁,躯干和四肢腹侧有弥漫性色素沉着。研究发现了 KIT 基因酪氨酸激酶(TK)结构域的四个种系变异:两个新变异 c.1990+1G>A(p.Pro627_Gly664delinsArg)和 c.2716T>C(p.Cys906Arg),以及两个已知变异 c.1879+1G>A(p.Gly592_Pro627delinsAla)和 c.1747G>A(p.Glu583Lys)。这两种剪接变异都会导致外显子跳过和 TK1 结构域的内切缺失。错义变体分别位于TK1和TK2结构域,损害了KIT下游的PI3K/AKT和MAPK/ERK信号通路。所有重症病例都与TK结构域的变异有关,从而引发了一种主要的显性阴性疾病机制:我们的数据扩大了 KIT 的突变谱,强调了严重病例中关键 TK 结构域变异的显性负效应。我们还分享了产前诊断的经验以及受影响家庭的知情生育选择。
{"title":"Novel Germline KIT Variants in Families With Severe Piebaldism: Case Series and Literature Review","authors":"Yuanyuan Zhang,&nbsp;Haiming Gao,&nbsp;Lu Zhang,&nbsp;Yunjing Zhao,&nbsp;Chuang Qiu,&nbsp;Xiaoliang Liu","doi":"10.1002/jcla.25073","DOIUrl":"10.1002/jcla.25073","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Piebaldism is a rare autosomal dominant disorder characterized by congenital white forelock and depigmented patches, which is most commonly caused by deleterious variants in the <i>KIT</i> gene.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Four <i>KIT</i> variants were identified in a piebaldism case series by whole-exome sequencing. Functional experiments, including in vitro minigene reporter assay and enzyme-linked immunosorbent assay, were carried out to elucidate the pathogenicity of the variants. The genotype–phenotype correlation was summarized through extensive literature reviewing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>All the four cases had severe piebaldism presented with typical white forelock and diffuse depigmentation on the ventral trunk and limbs. Four germline variants at the tyrosine kinase (TK) domains of the <i>KIT</i> gene were identified: two novel variants c.1990+1G&gt;A (p.Pro627_Gly664delinsArg) and c.2716T&gt;C (p.Cys906Arg), and two known variants c.1879+1G&gt;A (p.Gly592_Pro627delinsAla) and c.1747G&gt;A (p.Glu583Lys). Both splicing variants caused exon skipping and inframe deletions in the TK1 domain. The missense variants resided at the TK1 and TK2 domains respectively impairing PI3K/AKT and MAPK/ERK signaling pathways, the downstream of KIT. All severe cases were associated with variants in the TK domains, eliciting a major dominant-negative mechanism of the disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our data expand the mutation spectrum of <i>KIT</i>, emphasized by a dominant-negative effect of variants in the critical TK domains in severe cases. We also share the experience of prenatal diagnosis and informed reproductive choices for the affected families.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 11-12","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.25073","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141419319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections 抗体-抗生素共轭物:抗体-抗生素共轭物:抗细菌感染治疗潜力综述》(Antibody-Antibotic Conjugates: A Comprehensive Review on Their Treatment Potentials Against BacterialInfections.
IF 2.6 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-13 DOI: 10.1002/jcla.25071
Atieh Darbandi, Milad Abdi, Shirin Dashtbin, Sajad Yaghoubi, Mohammad Sholeh, Ebrahim Kouhsari, Talieh Darbandi, Roya Ghanavati, Behrouz Taheri

Introduction

Antibodies are significant agents in the immune system and have proven to be effective in treating bacterial infections. With the advancement of antibody engineering in recent decades, antibody therapy has evolved widely.

Aim

This review aimed to investigate a new method as a therapeutic platform for the treatment of bacterial infections and explore the novel features of this method in conferring pathogen specificity to broad-spectrum antibiotics.

Material and Methods

A literature review was conducted addressing the following topics about antibody–antibiotic conjugates (AACs): (1) structure and mechanism of action; (2) clinical effectiveness; (3) advantages and disadvantages.

Result

Antibody conjugates are designed to build upon the progress made in the development of monoclonal antibodies for the treatment of diseases. Despite the growing emergence of antibiotic resistance among pathogenic bacteria worldwide, novel antimicrobials have not been sufficiently expanded to combat the global crisis of antibiotic resistance. A recently developed strategy for the treatment of infectious diseases is the use of AACs, which are specifically activated only in host cells.

Conclusion

A novel therapeutic AAC employs an antibody to deliver the antibiotic to the bacteria. The AACs can release potent antibacterial components that unconjugated forms may not exhibit with an appropriate therapeutic index. This review highlights how this science has guided the design principles of an impressive AAC and discusses how the AAC model promises to enhance the antibiotic effect against bacterial infections.

引言抗体是免疫系统中的重要物质,已被证明能有效治疗细菌感染。目的:本综述旨在研究一种作为细菌感染治疗平台的新方法,并探讨该方法在赋予广谱抗生素病原体特异性方面的新特点:对抗体-抗生素共轭物(AACs)的以下内容进行了文献综述:(1) 结构和作用机制;(2) 临床效果;(3) 优缺点:抗体共轭物是在单克隆抗体治疗疾病的发展基础上设计的。尽管全球病原菌对抗生素的耐药性日益突出,但新型抗菌药物尚未得到充分推广,以应对全球抗生素耐药性危机。最近开发的一种治疗传染病的策略是使用 AAC,这种抗体只在宿主细胞中被特异性激活:结论:一种新型治疗性 AAC 利用抗体将抗生素传递给细菌。AACs 可以释放出有效的抗菌成分,而非结合型的 AACs 可能无法显示出适当的治疗指数。本综述重点介绍了这一科学如何指导令人印象深刻的 AAC 的设计原则,并讨论了 AAC 模型如何有望增强抗生素对细菌感染的效果。
{"title":"Antibody–Antibiotic Conjugates: A Comprehensive Review on Their Therapeutic Potentials Against BacterialInfections","authors":"Atieh Darbandi,&nbsp;Milad Abdi,&nbsp;Shirin Dashtbin,&nbsp;Sajad Yaghoubi,&nbsp;Mohammad Sholeh,&nbsp;Ebrahim Kouhsari,&nbsp;Talieh Darbandi,&nbsp;Roya Ghanavati,&nbsp;Behrouz Taheri","doi":"10.1002/jcla.25071","DOIUrl":"10.1002/jcla.25071","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Antibodies are significant agents in the immune system and have proven to be effective in treating bacterial infections. With the advancement of antibody engineering in recent decades, antibody therapy has evolved widely.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This review aimed to investigate a new method as a therapeutic platform for the treatment of bacterial infections and explore the novel features of this method in conferring pathogen specificity to broad-spectrum antibiotics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>A literature review was conducted addressing the following topics about antibody–antibiotic conjugates (AACs): (1) structure and mechanism of action; (2) clinical effectiveness; (3) advantages and disadvantages.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Result</h3>\u0000 \u0000 <p>Antibody conjugates are designed to build upon the progress made in the development of monoclonal antibodies for the treatment of diseases. Despite the growing emergence of antibiotic resistance among pathogenic bacteria worldwide, novel antimicrobials have not been sufficiently expanded to combat the global crisis of antibiotic resistance. A recently developed strategy for the treatment of infectious diseases is the use of AACs, which are specifically activated only in host cells.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A novel therapeutic AAC employs an antibody to deliver the antibiotic to the bacteria. The AACs can release potent antibacterial components that unconjugated forms may not exhibit with an appropriate therapeutic index. This review highlights how this science has guided the design principles of an impressive AAC and discusses how the AAC model promises to enhance the antibiotic effect against bacterial infections.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 10","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211676/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soluble Fibrinogen–Like Protein 2 Downregulation and Th17/Treg Imbalance in a Taurocholate-Induced Murine Experimental Model of Severe Acute Pancreatitis 陶罗胆酸诱导的小鼠重症急性胰腺炎实验模型中可溶性纤维蛋白原样蛋白 2 的下调与 Th17/Treg 失衡
IF 2.6 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-09 DOI: 10.1002/jcla.25076
Yibing Hu, Jin Ding, Yanping Chen, Qunying Wang, Xiaoyun Yang, Hongjun Hua, Xiaohua Ye

Background

Severe acute pancreatitis (SAP) is associated with tremendous systemic inflammation, T-helper 17 (Th17) cells, and regulatory T (Treg) cells play an essential role in the inflammatory responses. Meanwhile, soluble fibrinogen–like protein 2 (Sfgl2) is a critical immunosuppressive effector cytokine of Treg cells and modulates immune responses. However, the impact of SAP induction on Sfgl2 expression and the role of Sfgl2 in immunomodulation under SAP conditions are largely unknown.

Methods

A taurocholate-induced mouse SAP model was established. The ratios of CD4+CD25+Foxp3+ Treg cells or CD4+IL-17+ Th17 cells in blood and pancreatic tissues as well as surface expression of CD80, CD86, and major histocompatibility complex class II (MHC-II) were determined by flow cytometry. Gene mRNA expression was determined by qPCR. Serum amylase and soluble factors were quantitated by commercial kits. Bone marrow–derived dendritic cells (DCs) were generated, and NF-κB/p65 translocation was measured by immunofluorescence staining.

Results

SAP induction in mice decreased the Th17/Treg ratio in the pancreatic tissue and increased the Th17/Treg ratio in the peripheral blood. In addition, SAP was associated with a reduced level of Sfgl2 in the pancreatic tissue and blood: higher levels of serum IL-17, IL-2, IFN-α, and TNF-α, and lower levels of serum IL-4 and IL-10. Furthermore, the SAP-induced reduction in Sfgl2 expression was accompanied by dysregulated maturation of bone marrow–derived DCs.

Conclusions

SAP causes reduced Sfgl2 expression and Th17/Treg imbalance, thus providing critical insights for the development of Sfgl2- and Th17/Treg balance-targeted immunotherapies for patients with SAP.

背景:重症急性胰腺炎(SAP)与巨大的全身性炎症有关,T-helper 17(Th17)细胞和调节性T(Treg)细胞在炎症反应中起着至关重要的作用。同时,可溶性纤维蛋白原样蛋白 2(Sfgl2)是 Treg 细胞的一种重要的免疫抑制效应细胞因子,可调节免疫反应。然而,SAP诱导对Sfgl2表达的影响以及Sfgl2在SAP条件下免疫调节中的作用目前尚不清楚:方法:建立了牛磺胆酸盐诱导的小鼠SAP模型。方法:通过流式细胞术测定血液和胰腺组织中 CD4+CD25+Foxp3+ Treg 细胞或 CD4+IL-17+ Th17 细胞的比例,以及 CD80、CD86 和主要组织相容性复合体 II 类(MHC-II)的表面表达。基因 mRNA 表达通过 qPCR 进行测定。血清淀粉酶和可溶性因子用商业试剂盒定量。生成骨髓树突状细胞(DCs),并通过免疫荧光染色测定NF-κB/p65的转位:结果:SAP诱导小鼠降低了胰腺组织中Th17/Treg的比例,增加了外周血中Th17/Treg的比例。此外,SAP与胰腺组织和血液中Sfgl2水平降低有关:血清IL-17、IL-2、IFN-α和TNF-α水平升高,血清IL-4和IL-10水平降低。此外,SAP诱导的Sfgl2表达量减少还伴随着骨髓源性DC的成熟失调:结论:SAP会导致Sfgl2表达减少和Th17/Treg失衡,从而为开发针对SAP患者的Sfgl2-和Th17/Treg平衡的免疫疗法提供重要启示。
{"title":"Soluble Fibrinogen–Like Protein 2 Downregulation and Th17/Treg Imbalance in a Taurocholate-Induced Murine Experimental Model of Severe Acute Pancreatitis","authors":"Yibing Hu,&nbsp;Jin Ding,&nbsp;Yanping Chen,&nbsp;Qunying Wang,&nbsp;Xiaoyun Yang,&nbsp;Hongjun Hua,&nbsp;Xiaohua Ye","doi":"10.1002/jcla.25076","DOIUrl":"10.1002/jcla.25076","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Severe acute pancreatitis (SAP) is associated with tremendous systemic inflammation, T-helper 17 (Th17) cells, and regulatory T (Treg) cells play an essential role in the inflammatory responses. Meanwhile, soluble fibrinogen–like protein 2 (Sfgl2) is a critical immunosuppressive effector cytokine of Treg cells and modulates immune responses. However, the impact of SAP induction on Sfgl2 expression and the role of Sfgl2 in immunomodulation under SAP conditions are largely unknown.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A taurocholate-induced mouse SAP model was established. The ratios of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Treg cells or CD4<sup>+</sup>IL-17<sup>+</sup> Th17 cells in blood and pancreatic tissues as well as surface expression of CD80, CD86, and major histocompatibility complex class II (MHC-II) were determined by flow cytometry. Gene mRNA expression was determined by qPCR. Serum amylase and soluble factors were quantitated by commercial kits. Bone marrow–derived dendritic cells (DCs) were generated, and NF-κB/p65 translocation was measured by immunofluorescence staining.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>SAP induction in mice decreased the Th17/Treg ratio in the pancreatic tissue and increased the Th17/Treg ratio in the peripheral blood. In addition, SAP was associated with a reduced level of Sfgl2 in the pancreatic tissue and blood: higher levels of serum IL-17, IL-2, IFN-α, and TNF-α, and lower levels of serum IL-4 and IL-10. Furthermore, the SAP-induced reduction in Sfgl2 expression was accompanied by dysregulated maturation of bone marrow–derived DCs.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>SAP causes reduced Sfgl2 expression and Th17/Treg imbalance, thus providing critical insights for the development of Sfgl2- and Th17/Treg balance-targeted immunotherapies for patients with SAP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 10","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141296149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of Reference Range for Serum Concentration of Vitamin A and Vitamin E in Southern Sichuan Area of China 中国四川南部地区血清中维生素 A 和维生素 E 浓度参考范围的确定。
IF 2.6 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-07 DOI: 10.1002/jcla.25074
Qiang Ye, Qiang Zhong, Guoping Huang, Wen Zhang

Objective

To establish the reference range of serum concentration of vitamin A (VA) and vitamin E (VE) in Southern Sichuan area of China.

Methods

From August 1, 2021, to May 31, 2023, 9482 blood tablets were received for the screening of VA and VE. The information was divided into four different age groups: ≤1 year old, 1< to ≤6 years, 6< to ≤17 years, and 17< to ≤59 years. In each age group, the four seasons were further subdivided into spring, summer, autumn, and winter, as well as male and female genders. The serum concentration of VA and VE was detected by liquid chromatography—tandem mass spectrometry (HPLC-MS), and the reference range was established for verification.

Results

The concentration of VA and VE in 9482 cases showed skewed distribution. When comparing between different age groups, the serum concentration of VA and VE was statistically significant (p < 0.05). While comparing different seasons, the serum VA levels in different seasons were significantly different (p < 0.05) except in summer and autumn. There was statistical significance in VE level in different seasons (p < 0.05). And while comparing different genders, there was no statistical significance in VA concentration levels (p > 0.05). The VE concentration levels were statistically significant (p < 0.05). The established reference range was established and verified, and the results were in accordance with the standard.

Conclusion

The reference range of VA and VE should be set according to different ages, different seasons, and different genders.

目的方法:从 2021 年 8 月 1 日至 2023 年 5 月 31 日,在四川南部地区开展血清维生素 A(VA)和维生素 E(VE)浓度的参考范围测定:方法:自 2021 年 8 月 1 日至 2023 年 5 月 31 日,共采集 9482 份血片用于维生素 A 和维生素 E 的筛查。资料分为四个不同年龄组:≤1 岁、1<~≤6 岁、6<~≤17 岁、17<~≤59 岁。每个年龄组又细分为春、夏、秋、冬四个季节和男女性别。采用液相色谱-串联质谱法(HPLC-MS)检测血清中VA和VE的浓度,并建立参考范围进行验证:结果:9482 个病例的 VA 和 VE 浓度呈偏态分布。不同年龄组血清中 VA 和 VE 浓度比较,差异有统计学意义(P 0.05)。VE 浓度水平也有统计学意义(P 结论:VA 和 VE 的参考值范围为 0.05%:应根据不同年龄、不同季节和不同性别设定 VA 和 VE 的参考范围。
{"title":"Establishment of Reference Range for Serum Concentration of Vitamin A and Vitamin E in Southern Sichuan Area of China","authors":"Qiang Ye,&nbsp;Qiang Zhong,&nbsp;Guoping Huang,&nbsp;Wen Zhang","doi":"10.1002/jcla.25074","DOIUrl":"10.1002/jcla.25074","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To establish the reference range of serum concentration of vitamin A (VA) and vitamin E (VE) in Southern Sichuan area of China.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>From August 1, 2021, to May 31, 2023, 9482 blood tablets were received for the screening of VA and VE. The information was divided into four different age groups: ≤1 year old, 1&lt; to ≤6 years, 6&lt; to ≤17 years, and 17&lt; to ≤59 years. In each age group, the four seasons were further subdivided into spring, summer, autumn, and winter, as well as male and female genders. The serum concentration of VA and VE was detected by liquid chromatography—tandem mass spectrometry (HPLC-MS), and the reference range was established for verification.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The concentration of VA and VE in 9482 cases showed skewed distribution. When comparing between different age groups, the serum concentration of VA and VE was statistically significant (<i>p</i> &lt; 0.05). While comparing different seasons, the serum VA levels in different seasons were significantly different (<i>p</i> &lt; 0.05) except in summer and autumn. There was statistical significance in VE level in different seasons (<i>p</i> &lt; 0.05). And while comparing different genders, there was no statistical significance in VA concentration levels (<i>p</i> &gt; 0.05). The VE concentration levels were statistically significant (<i>p</i> &lt; 0.05). The established reference range was established and verified, and the results were in accordance with the standard.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The reference range of VA and VE should be set according to different ages, different seasons, and different genders.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 10","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141283867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analytical Interference in Chemiluminescence Assay–Measured Angiotensin I, Angiotensin II, Aldosterone, and Renin 化学发光测定法测量的血管紧张素 I、血管紧张素 II、醛固酮和肾素的分析干扰。
IF 2.6 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-06-01 DOI: 10.1002/jcla.25045
Xiaohua Xu, Yongzhi Xu, Shengqiang Liang

Background

The interference can be a significant source of laboratory errors with the potential to cause immunoassay results to drift. Therefore, we evaluated the interference in various endogenous and exogenous substances on immunoassay for angiotensin I (Ang I), angiotensin II (Ang II), aldosterone, and renin in vitro.

Methods

Ten endogenous and eight exogenous substances were evaluated at supraphysiologic or supratherapeutic plasma levels using the screening study to identify potential interfering substances. Subsequently, potential interfering substances were further tested within maximum pathological or therapeutic plasma concentration ranges using the dose–response study to determine whether the interference has a significant bias. According to preset acceptance criteria, the interference in potential interfering substances for Ang I, Ang II, and renin and aldosterone assays was determined.

Results

Six potential interfering substances for Ang I immunoassays were identified, namely valsartan, nifedipine, spironolactone, cholesterol, hemoglobin, and triglyceride. Meanwhile, ethanol, nifedipine, spironolactone, heparin sodium, warfarin, hemoglobin, uric acid, cholesterol, and triglyceride appeared to have potential interference in the Ang II assay. Three identified as possible interferents for aldosterone immunoassays were glucose, valsartan, and spironolactone. Moreover, warfarin, valsartan, spironolactone, uric acid, cholesterol, bilirubin unconjugated, triglyceride, and hemoglobin were potential interfering substances for renin immunoassays. However, only spironolactone of these potential interfering substances exceeded preset mean bias limits (less than ±10.0%) in aldosterone immunoassays.

Conclusion

Exogenous spironolactone caused clinically significant interference in aldosterone immunoassays. Moreover, the interference in other substances was acceptable in Ang I, Ang II, and renin and aldosterone immunoassays.

背景:干扰是实验室误差的一个重要来源,有可能导致免疫测定结果漂移。因此,我们评估了各种内源性和外源性物质对体外血管紧张素 I(Ang I)、血管紧张素 II(Ang II)、醛固酮和肾素免疫测定的干扰:采用筛选研究法评估了超生理或超治疗血浆水平的 10 种内源性物质和 8 种外源性物质,以确定潜在的干扰物质。随后,利用剂量反应研究在最大病理或治疗血浆浓度范围内对潜在干扰物质进行进一步测试,以确定干扰是否会产生显著偏差。根据预设的接受标准,确定潜在干扰物质对 Ang I、Ang II、肾素和醛固酮测定的干扰:结果:确定了六种潜在干扰物质对 Ang I 免疫测定的干扰,分别是缬沙坦、硝苯地平、螺内酯、胆固醇、血红蛋白和甘油三酯。同时,乙醇、硝苯地平、螺内酯、肝素钠、华法林、血红蛋白、尿酸、胆固醇和甘油三酯似乎对 Ang II 检测有潜在干扰。葡萄糖、缬沙坦和螺内酯可能对醛固酮免疫测定产生干扰。此外,华法林、缬沙坦、螺内酯、尿酸、胆固醇、未结合胆红素、甘油三酯和血红蛋白也是肾素免疫测定的潜在干扰物质。然而,在醛固酮免疫测定中,这些潜在干扰物质中只有螺内酯超过了预设的平均偏差限(小于±10.0%):结论:外源性螺内酯会对醛固酮免疫测定产生明显的临床干扰。结论:外源性螺内酯会对醛固酮免疫测定产生明显的临床干扰,而其他物质对血管紧张素Ⅰ、血管紧张素Ⅱ、肾素和醛固酮免疫测定的干扰是可以接受的。
{"title":"Analytical Interference in Chemiluminescence Assay–Measured Angiotensin I, Angiotensin II, Aldosterone, and Renin","authors":"Xiaohua Xu,&nbsp;Yongzhi Xu,&nbsp;Shengqiang Liang","doi":"10.1002/jcla.25045","DOIUrl":"10.1002/jcla.25045","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The interference can be a significant source of laboratory errors with the potential to cause immunoassay results to drift. Therefore, we evaluated the interference in various endogenous and exogenous substances on immunoassay for angiotensin I (Ang I), angiotensin II (Ang II), aldosterone, and renin in vitro.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Ten endogenous and eight exogenous substances were evaluated at supraphysiologic or supratherapeutic plasma levels using the screening study to identify potential interfering substances. Subsequently, potential interfering substances were further tested within maximum pathological or therapeutic plasma concentration ranges using the dose–response study to determine whether the interference has a significant bias. According to preset acceptance criteria, the interference in potential interfering substances for Ang I, Ang II, and renin and aldosterone assays was determined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Six potential interfering substances for Ang I immunoassays were identified, namely valsartan, nifedipine, spironolactone, cholesterol, hemoglobin, and triglyceride. Meanwhile, ethanol, nifedipine, spironolactone, heparin sodium, warfarin, hemoglobin, uric acid, cholesterol, and triglyceride appeared to have potential interference in the Ang II assay. Three identified as possible interferents for aldosterone immunoassays were glucose, valsartan, and spironolactone. Moreover, warfarin, valsartan, spironolactone, uric acid, cholesterol, bilirubin unconjugated, triglyceride, and hemoglobin were potential interfering substances for renin immunoassays. However, only spironolactone of these potential interfering substances exceeded preset mean bias limits (less than ±10.0%) in aldosterone immunoassays.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Exogenous spironolactone caused clinically significant interference in aldosterone immunoassays. Moreover, the interference in other substances was acceptable in Ang I, Ang II, and renin and aldosterone immunoassays.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 10","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141186672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients 脾切除术对重型β地中海贫血患者自然杀伤细胞水平的影响
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-30 DOI: 10.1002/jcla.25046
Ayşegül Uğur Kurtoğlu, Sevcan Uğur, Mesut Göçer, Erdal Kurtoğlu

Aim

In this study, we investigated how splenectomy affects natural killer (NK) cell levels in patients with β-thalassemia major (β-TM).

Materials and Methods

Seventy patients with β-TM (38 splenectomized and 32 nonsplenectomized) and 25 healthy controls were included in this study. The hemogram parameters, ferritin, T lymphocyte, T-helper cell, T-suppressor cell, and NK cell numbers, were measured.

Results

The T lymphocyte (CD3+) level was found to be significantly higher in the patient group (p < 0.05). CD3+/CD4+ T lymphocytes were detected to be significantly higher in the patient group (p < 0.05). Although the CD3+/CD4+ T lymphocyte level was significantly higher in the nonsplenectomy group (p < 0.05), this was not the case in the splenectomy group. When the patient and control groups were compared, no significant difference was detected regarding CD3+/CD8+ T lymphocyte levels. CD3/CD16+CD56+ NK cell level was found to be significantly lower only in the splenectomy group than in the control group (p < 0.05). We found that there was a significant negative correlation between serum ferritin levels and both total lymphocyte (r = −0.617) and CD3+ lymphocyte (r = −0.718) levels in the control group (p < 0.05). A significant negative correlation was detected between serum ferritin levels and CD3/CD16+CD56+ NK cell levels in the patient group (r = −0.410) (p < 0.05).

Conclusion

Splenectomy reduces NK cell levels in patients with β-TM. The negative relationship between ferritin levels and NK cells indicates that ferritin levels should be kept under control in patients with β-TM.

目的:本研究探讨了脾切除术如何影响重型β地中海贫血(β-TM)患者的自然杀伤(NK)细胞水平:研究对象包括 70 名重型地中海贫血患者(38 名脾切除患者和 32 名非脾切除患者)和 25 名健康对照者。研究人员测量了血象参数、铁蛋白、T淋巴细胞、T辅助细胞、T抑制细胞和NK细胞的数量:发现患者组的 T 淋巴细胞(CD3+)水平明显高于非脾切除组(p +/CD4+ T 淋巴细胞水平明显高于非脾切除组(p +/CD8+ T 淋巴细胞水平。发现只有脾切除组的 CD3-/CD16+CD56+ NK 细胞水平明显低于对照组(对照组的 p + 淋巴细胞水平(r = -0.718),患者组的 p -/CD16+CD56+ NK 细胞水平(r = -0.410)(p 结论:脾切除会降低 NK 细胞水平:脾切除可降低β-TM患者的NK细胞水平。铁蛋白水平与 NK 细胞之间的负相关表明,β-TM 患者应控制铁蛋白水平。
{"title":"Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients","authors":"Ayşegül Uğur Kurtoğlu,&nbsp;Sevcan Uğur,&nbsp;Mesut Göçer,&nbsp;Erdal Kurtoğlu","doi":"10.1002/jcla.25046","DOIUrl":"10.1002/jcla.25046","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>In this study, we investigated how splenectomy affects natural killer (NK) cell levels in patients with β-thalassemia major (β-TM).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>Seventy patients with β-TM (38 splenectomized and 32 nonsplenectomized) and 25 healthy controls were included in this study. The hemogram parameters, ferritin, T lymphocyte, T-helper cell, T-suppressor cell, and NK cell numbers, were measured.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The T lymphocyte (CD3<sup>+</sup>) level was found to be significantly higher in the patient group (<i>p</i> &lt; 0.05). CD3<sup>+</sup>/CD4<sup>+</sup> T lymphocytes were detected to be significantly higher in the patient group (<i>p</i> &lt; 0.05). Although the CD3<sup>+</sup>/CD4<sup>+</sup> T lymphocyte level was significantly higher in the nonsplenectomy group (<i>p</i> &lt; 0.05), this was not the case in the splenectomy group. When the patient and control groups were compared, no significant difference was detected regarding CD3<sup>+</sup>/CD8<sup>+</sup> T lymphocyte levels. CD3<sup>−</sup>/CD16<sup>+</sup>CD56<sup>+</sup> NK cell level was found to be significantly lower only in the splenectomy group than in the control group (<i>p</i> &lt; 0.05). We found that there was a significant negative correlation between serum ferritin levels and both total lymphocyte (<i>r</i> = −0.617) and CD3<sup>+</sup> lymphocyte (<i>r</i> = −0.718) levels in the control group (<i>p</i> &lt; 0.05). A significant negative correlation was detected between serum ferritin levels and CD3<sup>−</sup>/CD16<sup>+</sup>CD56<sup>+</sup> NK cell levels in the patient group (<i>r</i> = −0.410) (<i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Splenectomy reduces NK cell levels in patients with β-TM. The negative relationship between ferritin levels and NK cells indicates that ferritin levels should be kept under control in patients with β-TM.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 9","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the QMAC-dRAST System Version 2.5 for Rapid Antimicrobial Susceptibility Testing of Gram-Negative Bacteria From Positive Blood Culture Broth and Subcultured Colony Isolates 评估 QMAC-dRAST 系统 2.5 版对阳性血培养肉汤和菌落分离培养物中革兰氏阴性菌的快速抗菌药敏感性测试。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-28 DOI: 10.1002/jcla.25043
Tae Yeul Kim, Minhee Kang, Hyang Jin Shim, On-Kyun Kang, Hee Jae Huh, Nam Yong Lee

Background

Rapid antimicrobial susceptibility testing (AST) for bloodstream infections (BSIs) facilitates the optimization of antimicrobial therapy, preventing antimicrobial resistance and improving patient outcomes. QMAC-dRAST (QuantaMatrix Inc., Korea) is a rapid AST platform based on microfluidic chip technology that performs AST directly using positive blood culture broth (PBCB). This study evaluated the performance of QMAC-dRAST for Gram-negative bacteria using PBCB and subcultured colony isolates, comparing it with that of VITEK 2 (bioMérieux, France) using broth microdilution (BMD) as the reference method.

Methods

We included 141 Gram-negative blood culture isolates from patients with BSI and 12 carbapenemase-producing clinical isolates of Enterobacterales spiked into blood culture bottles. QMAC-dRAST performance was evaluated using PBCB and colony isolates, whereas VITEK 2 and BMD were tested only on colony isolates.

Results

For PBCB, QMAC-dRAST achieved 92.1% categorical agreement (CA), 95.3% essential agreement (EA), with 1.8% very major errors (VMEs), 3.5% major errors (MEs), and 5.2% minor errors (mEs). With colony isolates, it exhibited 92.5% CA and 95.1% EA, with 2.0% VMEs, 3.2% MEs, and 4.8% mEs. VITEK 2 showed 94.1% CA and 96.0% EA, with 4.3% VMEs, 0.4% MEs, and 4.3% mEs. QMAC-dRAST yielded elevated error rates for specific antimicrobial agents, with high VMEs for carbapenems and aminoglycosides. The median time to result for QMAC-dRAST was 5.9 h for PBCB samples and 6.1 h for subcultured colony isolates.

Conclusions

The QMAC-dRAST system demonstrated considerable strengths and comparable performance to the VITEK 2 system; however, challenges were discerned with specific antimicrobial agents, underlining a necessity for improvement.

背景:针对血流感染(BSI)的快速抗菌药物药敏试验(AST)有助于优化抗菌药物治疗、预防抗菌药物耐药性并改善患者预后。QMAC-dRAST(韩国 QuantaMatrix 公司)是一种基于微流控芯片技术的快速 AST 平台,可直接使用阳性血培养肉汤(PBCB)进行 AST 检测。本研究评估了 QMAC-dRAST 使用 PBCB 和亚培养菌落分离物检测革兰氏阴性菌的性能,并将其与使用肉汤微稀释(BMD)作为参考方法的 VITEK 2(法国生物梅里埃公司)进行了比较:我们从 BSI 患者中采集了 141 份革兰氏阴性血培养分离物,并在血培养瓶中添加了 12 份产碳青霉烯酶的肠杆菌临床分离物。使用 PBCB 和菌落分离物对 QMAC-dRAST 的性能进行了评估,而 VITEK 2 和 BMD 仅对菌落分离物进行了测试:对于 PBCB,QMAC-dRAST 实现了 92.1% 的分类一致 (CA)、95.3% 的基本一致 (EA)、1.8% 的非常大误差 (VME)、3.5% 的大误差 (ME) 和 5.2% 的小误差 (mE)。对于菌落分离物,它显示出 92.5% 的 CA 和 95.1% 的 EA,其中 VME 占 2.0%,ME 占 3.2%,mE 占 4.8%。VITEK 2 的 CA 和 EA 分别为 94.1%和 96.0%,VMEs 为 4.3%,MEs 为 0.4%,mEs 为 4.3%。QMAC-dRAST 对特定抗菌药的错误率较高,碳青霉烯类和氨基糖苷类的 VME 较高。QMAC-dRAST检测PBCB样本的中位结果时间为5.9小时,亚培养菌落分离物的中位结果时间为6.1小时:结论:QMAC-dRAST 系统显示出相当大的优势,其性能可与 VITEK 2 系统媲美;但是,在特定抗菌剂方面存在挑战,因此有必要加以改进。
{"title":"Evaluation of the QMAC-dRAST System Version 2.5 for Rapid Antimicrobial Susceptibility Testing of Gram-Negative Bacteria From Positive Blood Culture Broth and Subcultured Colony Isolates","authors":"Tae Yeul Kim,&nbsp;Minhee Kang,&nbsp;Hyang Jin Shim,&nbsp;On-Kyun Kang,&nbsp;Hee Jae Huh,&nbsp;Nam Yong Lee","doi":"10.1002/jcla.25043","DOIUrl":"10.1002/jcla.25043","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Rapid antimicrobial susceptibility testing (AST) for bloodstream infections (BSIs) facilitates the optimization of antimicrobial therapy, preventing antimicrobial resistance and improving patient outcomes. QMAC-dRAST (QuantaMatrix Inc., Korea) is a rapid AST platform based on microfluidic chip technology that performs AST directly using positive blood culture broth (PBCB). This study evaluated the performance of QMAC-dRAST for Gram-negative bacteria using PBCB and subcultured colony isolates, comparing it with that of VITEK 2 (bioMérieux, France) using broth microdilution (BMD) as the reference method.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We included 141 Gram-negative blood culture isolates from patients with BSI and 12 carbapenemase-producing clinical isolates of Enterobacterales spiked into blood culture bottles. QMAC-dRAST performance was evaluated using PBCB and colony isolates, whereas VITEK 2 and BMD were tested only on colony isolates.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>For PBCB, QMAC-dRAST achieved 92.1% categorical agreement (CA), 95.3% essential agreement (EA), with 1.8% very major errors (VMEs), 3.5% major errors (MEs), and 5.2% minor errors (mEs). With colony isolates, it exhibited 92.5% CA and 95.1% EA, with 2.0% VMEs, 3.2% MEs, and 4.8% mEs. VITEK 2 showed 94.1% CA and 96.0% EA, with 4.3% VMEs, 0.4% MEs, and 4.3% mEs. QMAC-dRAST yielded elevated error rates for specific antimicrobial agents, with high VMEs for carbapenems and aminoglycosides. The median time to result for QMAC-dRAST was 5.9 h for PBCB samples and 6.1 h for subcultured colony isolates.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The QMAC-dRAST system demonstrated considerable strengths and comparable performance to the VITEK 2 system; however, challenges were discerned with specific antimicrobial agents, underlining a necessity for improvement.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 9","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141158335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5-Year Countrywide Study 中aseomyces glabrata 菌种群的分子流行病学和抗真菌药敏谱:一项为期 5 年的全国性研究。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-22 DOI: 10.1002/jcla.25042
Maryam Salimi, Javad Javidnia, Leila Faeli, Azam Moslemi, Mohammad Taghi Hedayati, Iman Haghani, Seyed Reza Aghili, Maryam Moazeni, Parisa Badiee, Maryam Roudbari, Hossein Zarrinfar, Rasoul Mohammadi, Ensieh Lotfali, Sadegh Nouripour-Sisakht, Seyedmojtaba Seyedmousavi, Tahereh Shokohi, Mahdi Abastabar

Background

The current study aimed to identify Iranian Nakaseomyces (Candida) glabrata complex species in the clinical isolates and determine their antifungal susceptibility profile.

Methods

In total, 320 N. glabrata clinical isolates were collected from patients hospitalized in different geographical regions of Iran. The initial screening was performed by morphological characteristics on CHROMagar Candida. Each isolate was identified by targeting the D1/D2 rDNA using a multiplex-PCR method. To validate the mPCR method and determine genetic diversity, the ITS-rDNA region was randomly sequenced in 40 isolates. Additionally, antifungal susceptibility was evaluated against nine antifungal agents following the CLSI M27-A4 guidelines.

Results

All clinical isolates from Iran were identified as N. glabrata. The analysis of ITS-rDNA sequence data revealed the presence of eight distinct ITS clades and 10 haplotypes among the 40 isolates of N. glabrata. The predominant clades identified were Clades VII, V, and IV, which respectively accounted for 22.5%, 17.5%, and 17.5% isolates. The widest MIC ranges were observed for voriconazole (0.016–8 μg/mL) and isavuconazole (0.016–2 μg/mL), whereas the narrowest ranges were seen with itraconazole and amphotericin B (0.25–2 μg/mL).

Conclusion

Haplotype diversity can be a valuable approach for studying the genetic diversity, transmission patterns, and epidemiology of the N. glabrata complex.

背景:本研究旨在从临床分离物中鉴定伊朗中生孢子菌(光滑念珠菌)复合菌种,并确定其抗真菌药敏谱:目前的研究旨在从临床分离物中鉴定伊朗草履薄念珠菌(Nakaseomyces (Candida) glabrata)复合菌种,并确定其抗真菌药敏谱:方法:研究人员从伊朗不同地区的住院患者身上共采集了 320 株临床分离株。在 CHROMagar 念珠菌培养基上根据形态特征进行初步筛选。使用多重 PCR 方法以 D1/D2 rDNA 为靶标对每个分离株进行鉴定。为了验证 mPCR 方法并确定遗传多样性,对 40 个分离物的 ITS-rDNA 区域进行了随机测序。此外,还根据 CLSI M27-A4 指南对九种抗真菌剂进行了抗真菌敏感性评估:结果:来自伊朗的所有临床分离物均被鉴定为 N. glabrata。对 ITS-rDNA 序列数据的分析表明,在 40 个 N. glabrata 分离物中存在 8 个不同的 ITS 支系和 10 个单倍型。主要的支系为支系 VII、V 和 IV,分别占分离株的 22.5%、17.5% 和 17.5%。伏立康唑(0.016-8 μg/mL)和异武康唑(0.016-2 μg/mL)的 MIC 范围最广,而伊曲康唑和两性霉素 B(0.25-2 μg/mL)的 MIC 范围最窄:单倍型多样性是研究玻璃疽杆菌复合体遗传多样性、传播模式和流行病学的一种有价值的方法。
{"title":"Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5-Year Countrywide Study","authors":"Maryam Salimi,&nbsp;Javad Javidnia,&nbsp;Leila Faeli,&nbsp;Azam Moslemi,&nbsp;Mohammad Taghi Hedayati,&nbsp;Iman Haghani,&nbsp;Seyed Reza Aghili,&nbsp;Maryam Moazeni,&nbsp;Parisa Badiee,&nbsp;Maryam Roudbari,&nbsp;Hossein Zarrinfar,&nbsp;Rasoul Mohammadi,&nbsp;Ensieh Lotfali,&nbsp;Sadegh Nouripour-Sisakht,&nbsp;Seyedmojtaba Seyedmousavi,&nbsp;Tahereh Shokohi,&nbsp;Mahdi Abastabar","doi":"10.1002/jcla.25042","DOIUrl":"10.1002/jcla.25042","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The current study aimed to identify Iranian <i>Nakaseomyces</i> (<i>Candida</i>) <i>glabrata</i> complex species in the clinical isolates and determine their antifungal susceptibility profile.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In total, 320 <i>N. glabrata</i> clinical isolates were collected from patients hospitalized in different geographical regions of Iran. The initial screening was performed by morphological characteristics on CHROMagar <i>Candida</i>. Each isolate was identified by targeting the D1/D2 rDNA using a multiplex-PCR method. To validate the mPCR method and determine genetic diversity, the ITS-rDNA region was randomly sequenced in 40 isolates. Additionally, antifungal susceptibility was evaluated against nine antifungal agents following the CLSI M27-A4 guidelines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>All clinical isolates from Iran were identified as <i>N. glabrata</i>. The analysis of ITS-rDNA sequence data revealed the presence of eight distinct ITS clades and 10 haplotypes among the 40 isolates of <i>N. glabrata</i>. The predominant clades identified were Clades VII, V, and IV, which respectively accounted for 22.5%, 17.5%, and 17.5% isolates. The widest MIC ranges were observed for voriconazole (0.016–8 μg/mL) and isavuconazole (0.016–2 μg/mL), whereas the narrowest ranges were seen with itraconazole and amphotericin B (0.25–2 μg/mL).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Haplotype diversity can be a valuable approach for studying the genetic diversity, transmission patterns, and epidemiology of the <i>N. glabrata</i> complex.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 9","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock 可溶性尿激酶凝血活酶原受体(suPAR)作为小儿败血症休克死亡率早期指标的作用。
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-06 DOI: 10.1002/jcla.25040
Caner Turan, Ali Yurtseven, Pinar Yazici Ozkaya, Elif Azarsiz, Eylem Ulas Saz

Background

Despite advancements in antibiotic therapy and resuscitation protocols, sepsis and septic shock remain major contributors to morbidity and mortality in children. We aimed to investigate the utility of soluble urokinase plasminogen activator receptor (suPAR) for the early detection of septic shock and to evaluate its accuracy in predicting mortality.

Methods

A prospective study was conducted in a tertiary pediatric emergency department (ED), enrolling patients diagnosed with the sepsis, severe sepsis, or septic shock. In addition to assessing infection biomarkers such as C-reactive protein and procalcitonin, suPAR levels were quantified upon admission using enzyme-linked immunosorbent assay. The primary outcome measure was 30-day mortality.

Results

Overall 72 patients and 80 healthy children included. Plasma suPAR levels demonstrated a statistically significant elevation in the sepsis, severe sepsis, and septic shock groups compared with the control group (p < 0.001 for all). The septic shock group exhibited the highest suPAR levels upon admission, surpassing both the sepsis and severe sepsis groups (p = 0.009 and 0.042). ROC analysis underscored the promising potential of suPAR with an AUC of 0.832 for septic shock. Analysis of mortality prediction revealed significantly higher suPAR levels in nonsurvivors than survivors (9.7 ng/mL vs. 4.2 ng/mL; p < 0.001). Employing plasma suPAR levels to discriminate between mortality and survival, a threshold of ≥7.0 ng/mL demonstrated a sensitivity of 90.9% and specificity of 71.0%.

Conclusion

Plasma suPAR levels have the potential as a biomarker for predicting mortality in children with septic shock. In pediatric septic shock, the presence of plasma suPAR ≥7 ng/mL along with an underlying disease significantly increases the risk of mortality.

背景:尽管抗生素治疗和复苏方案取得了进步,但败血症和脓毒性休克仍是导致儿童发病和死亡的主要原因。我们旨在研究可溶性尿激酶纤溶酶原激活物受体(suPAR)对早期检测脓毒性休克的作用,并评估其预测死亡率的准确性:在一家三级儿科急诊科(ED)开展了一项前瞻性研究,纳入了被诊断为脓毒症、严重脓毒症或脓毒性休克的患者。除了评估 C 反应蛋白和降钙素原等感染生物标志物外,还在患者入院时使用酶联免疫吸附试验对 suPAR 水平进行了量化。主要结果指标为 30 天死亡率:结果:共纳入 72 名患者和 80 名健康儿童。与对照组相比,脓毒症组、严重脓毒症组和脓毒性休克组的血浆 suPAR 水平有统计学意义的显著升高(p 结论:血浆 suPAR 水平对脓毒症、严重脓毒症和脓毒性休克有显著的抑制作用:血浆 suPAR 水平有可能成为预测脓毒性休克患儿死亡率的生物标志物。在小儿脓毒性休克中,血浆 suPAR≥7 纳克/毫升并伴有潜在疾病会显著增加死亡风险。
{"title":"The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock","authors":"Caner Turan,&nbsp;Ali Yurtseven,&nbsp;Pinar Yazici Ozkaya,&nbsp;Elif Azarsiz,&nbsp;Eylem Ulas Saz","doi":"10.1002/jcla.25040","DOIUrl":"10.1002/jcla.25040","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Despite advancements in antibiotic therapy and resuscitation protocols, sepsis and septic shock remain major contributors to morbidity and mortality in children. We aimed to investigate the utility of soluble urokinase plasminogen activator receptor (suPAR) for the early detection of septic shock and to evaluate its accuracy in predicting mortality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A prospective study was conducted in a tertiary pediatric emergency department (ED), enrolling patients diagnosed with the sepsis, severe sepsis, or septic shock. In addition to assessing infection biomarkers such as C-reactive protein and procalcitonin, suPAR levels were quantified upon admission using enzyme-linked immunosorbent assay. The primary outcome measure was 30-day mortality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Overall 72 patients and 80 healthy children included. Plasma suPAR levels demonstrated a statistically significant elevation in the sepsis, severe sepsis, and septic shock groups compared with the control group (<i>p</i> &lt; 0.001 for all). The septic shock group exhibited the highest suPAR levels upon admission, surpassing both the sepsis and severe sepsis groups (<i>p</i> = 0.009 and 0.042). ROC analysis underscored the promising potential of suPAR with an AUC of 0.832 for septic shock. Analysis of mortality prediction revealed significantly higher suPAR levels in nonsurvivors than survivors (9.7 ng/mL vs. 4.2 ng/mL; <i>p</i> &lt; 0.001). Employing plasma suPAR levels to discriminate between mortality and survival, a threshold of ≥7.0 ng/mL demonstrated a sensitivity of 90.9% and specificity of 71.0%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Plasma suPAR levels have the potential as a biomarker for predicting mortality in children with septic shock. In pediatric septic shock, the presence of plasma suPAR ≥7 ng/mL along with an underlying disease significantly increases the risk of mortality.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 9","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11137844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140857256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year 用 Sysmex XN 1000 对一岁以下儿童进行有核红细胞自动计数与显微镜参照的比较评估
IF 2.7 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-04-15 DOI: 10.1002/jcla.25037
Sophie Brunner-Ziegler, Bernd Jilma, Gabriele Grimm, Petra Jilma-Stohlawetz

Background

In newborns, elevated nucleated red blood cell (NRBC) levels can be associated with enhanced erythropoietic stress and might be predictive for adverse outcome. Also, the presence of NRBC in peripheral blood might lead to erroneous enumeration results of white blood cells in automated hematology analyzers. We aimed to assess the comparability of the Sysmex XN 1000 to manual slide reviews and correlation of NRBC with inflammation markers.

Methods

Specimens of 3397 children under 1 year were compared by automated and microscopic NRBC enumeration. Additionally, potential correlations between NRBC and age and inflammation markers were examined.

Results

Overall, there was good correlation (r = 0.97) between automated (range: 0%–3883%) and microscopic enumeration (range: 0%–3694%) of NRBC with high comparability up to a NRBC value of 200% and an increase in the variation between the two methods with increasing NRBC numbers. When 94 samples with ≤ 200% NRBC and ≥ 30% divergence between methods were separately reanalyzed with respect to overlapping cell populations in their scattergrams, Sysmex would have generated unrecognized incorrect automated results in 47 samples, corresponding to 1.4% of total study samples. NRBC counts were negatively correlated to age, but not to inflammation markers.

Conclusion

Sysmex XN 1000 is highly precise in the enumeration of NRBC in children under 1 year up to counts of 200% and might replace time-intense manual counting in routine diagnostics. In the setting of neonatal and intensive care diagnostics, microscopic control and supervision of scattergrams are highly recommended for any automated NRBC enumeration processes.

背景在新生儿中,有核红细胞(NRBC)水平升高可能与红细胞生成压力增加有关,并可能预示着不良预后。此外,外周血中 NRBC 的存在可能会导致自动血液分析仪中白细胞计数结果的错误。我们的目的是评估 Sysmex XN 1000 与手动玻片审查的可比性以及 NRBC 与炎症标记物的相关性。结果总体而言,NRBC 的自动计数(范围:0%-3883%)与显微镜计数(范围:0%-3694%)之间具有良好的相关性(r = 0.97),在 NRBC 值达到 200% 时具有很高的可比性,并且随着 NRBC 数量的增加,两种方法之间的差异也在增加。如果对 NRBC 值≤ 200% 且两种方法之间差异≥ 30% 的 94 个样本分别重新分析其散点图中重叠的细胞群,Sysmex 会在 47 个样本中生成无法识别的错误自动结果,相当于研究样本总数的 1.4%。NRBC 计数与年龄呈负相关,但与炎症标志物无相关性。在新生儿和重症监护诊断中,强烈建议对任何自动 NRBC计数流程进行显微镜控制和散点图监督。
{"title":"Comparison Evaluation of Automated Nucleated Red Blood Cell Enumeration by Sysmex XN 1000 in Comparison With Microscopic Reference in Children Under 1 Year","authors":"Sophie Brunner-Ziegler,&nbsp;Bernd Jilma,&nbsp;Gabriele Grimm,&nbsp;Petra Jilma-Stohlawetz","doi":"10.1002/jcla.25037","DOIUrl":"10.1002/jcla.25037","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>In newborns, elevated nucleated red blood cell (NRBC) levels can be associated with enhanced erythropoietic stress and might be predictive for adverse outcome. Also, the presence of NRBC in peripheral blood might lead to erroneous enumeration results of white blood cells in automated hematology analyzers. We aimed to assess the comparability of the Sysmex XN 1000 to manual slide reviews and correlation of NRBC with inflammation markers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Specimens of 3397 children under 1 year were compared by automated and microscopic NRBC enumeration. Additionally, potential correlations between NRBC and age and inflammation markers were examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Overall, there was good correlation (<i>r</i> = 0.97) between automated (range: 0%–3883%) and microscopic enumeration (range: 0%–3694%) of NRBC with high comparability up to a NRBC value of 200% and an increase in the variation between the two methods with increasing NRBC numbers. When 94 samples with ≤ 200% NRBC and ≥ 30% divergence between methods were separately reanalyzed with respect to overlapping cell populations in their scattergrams, Sysmex would have generated unrecognized incorrect automated results in 47 samples, corresponding to 1.4% of total study samples. NRBC counts were negatively correlated to age, but not to inflammation markers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Sysmex XN 1000 is highly precise in the enumeration of NRBC in children under 1 year up to counts of 200% and might replace time-intense manual counting in routine diagnostics. In the setting of neonatal and intensive care diagnostics, microscopic control and supervision of scattergrams are highly recommended for any automated NRBC enumeration processes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"38 8","pages":""},"PeriodicalIF":2.7,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.25037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140574888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Laboratory Analysis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1